These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Aarestrup FM Microb Drug Resist; 1995; 1(3):255-7. PubMed ID: 9158784 [No Abstract] [Full Text] [Related]
26. Symposium on antimicrobial therapy. IX. The glycopeptide and macrolide antibiotics. Greenfield RA J Okla State Med Assoc; 1993 Jun; 86(6):269-75. PubMed ID: 8326418 [No Abstract] [Full Text] [Related]
27. [Interactions between bacteria and antimicrobials during the postantibiotic effect phase]. Pastor A; Cantón E Rev Esp Quimioter; 1999 Dec; 12(4):294-9. PubMed ID: 10855007 [No Abstract] [Full Text] [Related]
30. Resistance of enterococci to aminoglycosides and glycopeptides. Leclercq R; Dutka-Malen S; Brisson-Noël A; Molinas C; Derlot E; Arthur M; Duval J; Courvalin P Clin Infect Dis; 1992 Sep; 15(3):495-501. PubMed ID: 1520800 [TBL] [Abstract][Full Text] [Related]
31. [In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic Gram-positive bacteria]. Malkova IV; Borisova OK; Pavlova MV; Zemlianitskaia EP; Sergeeva TI Antibiot Khimioter; 1991 Apr; 36(4):17-20. PubMed ID: 1654046 [TBL] [Abstract][Full Text] [Related]
32. [Infectious endocarditis caused by a glycopeptide-resistant enterococus]. Jouaihia W; Ghozzi R; Kamoun A; Baccar H; Bousnina A; Ben Redjeb S Tunis Med; 2000 Nov; 78(11):667-70. PubMed ID: 11155391 [TBL] [Abstract][Full Text] [Related]
33. Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria. Yarlagadda V; Samaddar S; Paramanandham K; Shome BR; Haldar J Angew Chem Int Ed Engl; 2015 Nov; 54(46):13644-9. PubMed ID: 26473305 [TBL] [Abstract][Full Text] [Related]
34. Glycopeptide resistance in enterococci. Méndez-Alvarez S; Pérez-Hernández X; Claverie-Martín F Int Microbiol; 2000 Jun; 3(2):71-80. PubMed ID: 11001535 [TBL] [Abstract][Full Text] [Related]
35. [Negative results of the determination of sensitivity to antibiotics of body microflora in connection with appearance of dysbacteriosis]. Chernomordik AB Lab Delo; 1969; 3():154-7. PubMed ID: 4185179 [No Abstract] [Full Text] [Related]
36. Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands. Mevius D; Devriese L; Butaye P; Vandamme P; Verschure M; Veldman K J Antimicrob Chemother; 1998 Aug; 42(2):275-6. PubMed ID: 9738855 [No Abstract] [Full Text] [Related]
37. [Characteristic of antibiotics and the administrative methods in basic chemotherapy of bacterial infections]. Totsuka K Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1627-31. PubMed ID: 2079585 [No Abstract] [Full Text] [Related]
38. Mechanism of action of oritavancin and related glycopeptide antibiotics. Allen NE; Nicas TI FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393 [TBL] [Abstract][Full Text] [Related]
39. [New quinolones]. Matsumoto F; Morita M; Sato Y Nihon Rinsho; 1990 Oct; 48(10):2205-11. PubMed ID: 2177796 [No Abstract] [Full Text] [Related]